TOUR

Tuniu Corporation

There isn't enough reported data to score TOUR yet.

TOUR Fundamentals

MetricStatus
Healthy
Stable
Under pressure
Healthy

TOUR's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.

TOUR PE Valuation

TOUR has no meaningful PE right now: it lost money over the past year.

TOUR Forward outlook

There aren't enough analyst estimates for TOUR to show an outlook.

TOUR Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $4.69 on Nov 12.

There is not enough scenario data to assess TOUR's risk to reward.

TOUR Earnings Per Share

Q3 2025: $0.23Q4 2025: $1.23
Q3 2025: $0.23Q4 2025: $1.23

TOUR Quarterly Revenue

Q2 2023: $15MQ3 2023: $27MQ4 2023: $15MQ1 2024: $16MQ2 2024: $18MQ3 2024: $28MQ4 2024: $15MQ1 2025: $18MQ2 2025: $20MQ3 2025: $30MQ4 2025: $19MQ1 2026: $20M
Q2 2023: $15MQ3 2023: $27MQ4 2023: $15MQ1 2024: $16MQ2 2024: $18MQ3 2024: $28MQ4 2024: $15MQ1 2025: $18MQ2 2025: $20MQ3 2025: $30MQ4 2025: $19MQ1 2026: $20M
QuarterRevenueYoY
Q1 2026$19.9M+13%
Q4 2025$18.5M+20%
Q3 2025$30.3M+8.6%
Q2 2025$20.2M+15%
Q1 2025$17.6M+8.9%
Q4 2024$15.4M+2.8%
Q3 2024$27.9M+4.4%
Q2 2024$17.5M+17%

TOUR's revenue has grown year over year for 13 quarters in a row: $20M last quarter, up 13% from the same quarter a year ago.

TOUR Free Cash Flow

Q2 2023: $256,400Q3 2023: $250,463Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: --Q4 2025: --Q1 2026: --
Q2 2023: $256,400Q3 2023: $250,463Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: --Q4 2025: --Q1 2026: --
QuarterFree cash flowYoY
Q2 2025$0$0
Q1 2025$0$0
Q4 2024$0$0
Q3 2024$0-100%
Q2 2024$0-100%
Q1 2024$0-100%
Q4 2023$0-100%
Q3 2023$250.5K-44%

TOUR's free cash flow has been positive every quarter since mid-2020: $0 over the past year, against $250,463 the year before.

TOUR Total Shares

Q4 2024: 4MQ1 2025: 4MQ2 2025: 4MQ3 2025: 4MQ4 2025: 4M
Q4 2024: 4MQ1 2025: 4MQ2 2025: 4MQ3 2025: 4MQ4 2025: 4M
PeriodChange %Net change
Quarterly-2.3%-88.5K shares
1 year-5.8%-230K shares

TOUR has 4M diluted shares, down 5.8% from a year ago.

TOUR Net Leverage

Q4 2023: -2.3xQ1 2024: -4.9xQ2 2024: -6.7xQ3 2024: -3.8xQ4 2024: -5.9xQ1 2025: -16.8xQ2 2025: -14.7xQ3 2025: -34.6xQ4 2025: -3.2xQ1 2026: -5.8x
Q4 2023: -2.3xQ1 2024: -4.9xQ2 2024: -6.7xQ3 2024: -3.8xQ4 2024: -5.9xQ1 2025: -16.8xQ2 2025: -14.7xQ3 2025: -34.6xQ4 2025: -3.2xQ1 2026: -5.8x
QuarterNet LeverageStatus
Q1 2026-5.8xNet Cash
Q4 2025-3.2xNet Cash
Q3 2025-34.6xNet Cash
Q2 2025-14.7xNet Cash
Q1 2025-16.8xNet Cash
Q4 2024-5.9xNet Cash
Q3 2024-3.8xNet Cash
Q2 2024-6.7xNet Cash

TOUR has more cash than debt.

TOUR Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic12.5Oversold

TOUR's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

TOUR PE vs Consumer Cyclical Sector

TOUR has no meaningful PE right now: it lost money over the past year.

TOUR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.863.5% below
20 week MA$4.955.3% below
50 week MA$5.9421% below
100 week MA$7.5338% below
200 week MA$9.6351% below

TOUR is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.

TOUR Yearly ROI

YearStart priceEnd priceROI
2020$23.5$19.2-18%
2021$19.2$9.78-49%
2022$9.78$16.7+71%
2023$16.7$6.71-60%
2024$6.71$9.85+47%
2025$9.85$7.25-26%
2026 YTD$7.25$4.69-35%

TOUR has finished lower in four of the last six years. It's down 35% so far in 2026.

Give your agent the market.

Get API key